Agreed. What's not to like about the next 6+ months. New, easy to administer, high value formulation with the same properties that have previously shown CPACS will be in patients and clinically validated, opening up blockbuster commerical opportunities in the not too distant future. FOMO will be a factor, as there's not much time to be on the sidelines anymore.
RAC - Charts & Price Action, page-20316
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
-0.025(1.56%) |
Mkt cap ! $268.0M | |||
| Open | High | Low | Value | Volume |
| $1.59 | $1.62 | $1.58 | $56.45K | 35.42K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 700 | $1.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.60 | 1938 | 2 |
View Market Depth
| Last trade - 13.17pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.59 |
Change
-0.025 ( 0.63 %) |
||||
| Open | High | Low | Volume | ||
| $1.58 | $1.62 | $1.56 | 4293 | ||
| Last updated 14.09pm 05/06/2024 ? | |||||
| RAC (ASX) Chart |